Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare
Vaxcyte, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -923.7M | -569.5M | -388.3M | -207.3M | -102.1M | -87.1M |
| EBITDA | -898.8M | -448.1M | -315.2M | -189.8M | -98.3M | -85.5M |
| Net Income | -766.6M | -463.9M | -402.3M | -223.5M | -100.1M | -89.2M |
| Per Share Data | ||||||
| EPS (diluted) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 |
| Shares Outstanding (dil.) | 136M | 122M | 97M | 65M | 52M | 30M |
Vaxcyte, Inc. Income Statement — FAQ
Vaxcyte, Inc. (PCVX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCVX's income statement history?
The chart and table above show Vaxcyte, Inc.'s income statement by year and by quarter, including the growth rate.